This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obagi Medical Products And Suneva Medical Partner To Offer ReGenica® Facial Rejuvenation Complex

Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin-health systems, and Suneva Medical, Inc., a rapidly growing aesthetics company, jointly announce a partnership to co-distribute ReGenica Facial Rejuvenation Complex.

This technologically advanced product supports a more rapid improvement in the appearance of post-laser skin by fusing the promise of stem cells with the power of growth factors. It has been clinically proven to accelerate the return of healthy appearing skin after a combination ablative/nonablative laser treatment compared to a vehicle control in two separate studies published in peer-reviewed journals 1,2. Obagi is extremely pleased to be co-distributing the ReGenica Facial Rejuvenation Complex, along with the Suneva sales force. It can now offer a clinically proven post-procedure solution to its physicians and their patients.

ReGenica's secret lies in its Multipotent CCM Complex (Cell Conditioned Media) developed by Dr. Gail K. Naughton, a renowned pioneer in the field of regenerative medicine. CCM is a highly potent composition of active growth factors and proteins not found in any other skincare product and developed through a revolutionary and highly proprietary scientific method. Only ReGenica contains this breakthrough, bovine serum-free, multipotent CCM in an innovative formulation optimized with the most advanced cosmeceutical skin conditioning agents.

“Obagi is delighted to offer another revolutionary skincare solution to patients. The addition of the ReGenica line solidifies already existing evidence that Obagi is dedicated to delivering the most efficacious, innovative products to patients seeking real solutions,” Al Hummel, Obagi’s President and CEO, said. “The Facial Rejuvenation Complex addresses the need for post-procedure skincare treatments that are not only gentle and safe for compromised skin, but also accelerate the visible improvement in the appearance of side effects associated with procedures.”

“Obagi has significant expertise and a proven track record of marketing physician-dispensed products. We believe this relationship will accelerate our penetration in the marketplace and bring ReGenica Facial Rejuvenation Complex to more physicians in need of a cutting edge post-procedure solution and are excited to have a company as successful as Obagi as our partner,” commented Nicholas Teti, Chairman and Chief Executive Officer of Suneva Medical.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs